UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST: The aim of the study is to establish the value of microbleeds (MB) and genetic factors in predicting symptomatic ICH following anticoagulation to prevent recurrent ischaemic stroke
Data-sharing agreement from NHS Digital registers of approved data releases, 2014–2019. Evidence status: source reported.
- Organisation
- UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST
- Source reference
- DARS-NIC-148324-V6WWJ-v0.0
- Jurisdiction
- England
- Licence
- Open Government Licence v3.0, subject to NHS England terms and exclusions
The aim of the study is to establish the value of microbleeds (MB) and genetic factors in predicting symptomatic ICH following anticoagulation to prevent recurrent ischaemic stroke due to AF.
- Register reference
- DARS-NIC-148324-V6WWJ-v0.0
- Agreement period
- not published to no end date published
- For commercial purposes (as marked in the register)
- Not stated
- Release files listed by NHS England
- 2
Data approved
- MRIS - Cause of Death Report
- MRIS - Cohort Event Notification Report
Objective, as published
The aim of the study is to establish the value of microbleeds (MB) and genetic factors in predicting symptomatic ICH following anticoagulation to prevent recurrent ischaemic stroke due to AF.
Source: https://webarchive.nationalarchives.gov.uk/ukgwa/2019/http://content.digital.nhs.uk/media/23167/Data-Release-Register-September---November-2016/xls/Data_Release_Register__September_-_November_2016.xlsx. Captured 2026-10-30.
Limitations: Agreement as recorded in an NHS Digital register of approved data releases (2014–2019), retrieved from the UK Government Web Archive. That register lists releases made in its period and the agreement's purpose statement as it then stood; it gives no agreement dates, and the agreement may have changed since. Imported only where a paper quotes a reference no current register holds.